1 The effect of intracerebroventricularly (i.c.v) administered prostaglandin E2 (PGE2) on gastric acid secretion was studied in anaesthetized rats.
Introduction
It is well accepted that the central nervous system is involved in the control of gastric acid secretion, and several brain structures and neural pathways participating in this process have been identified (Grijalva, Lindholm & Novin, 1980) . In addition, biochemical signals in the brain initiating or modulating neural and humoral impulses for gastric acid secretion have also been investigated in recent years. Thus it has been proposed that cholinergic (Brodie, Lotti & Bauer, 1970) , noradrenergic (Osumi, Aibara, Sakae & Fujiwara, 1977) , 5-hydroxytryptaminergic (Hierro, Sanchez-Barriga, Solana & Pefla, 1980) and GABA-ergic (Levine, Morley, Kneip, Grace & Silvis, 1981) systems, as well as several neuropeptides (Tache, Vale, Rivier & Brown, 1981) , may be involved in the central regulation of gastric acid secretion.
Various prostaglandins, including prostaglandin E2 (PGE2), are found in the central nervous system (Wolfe, 1982) , and when administered to experimental animals they modify a number of physiological functions by a central action. There is now evidence that prostaglandins have centrally-mediated effects on thermoregulation, cardiovascular system, respiration, hypothalamic and pituitary hormone release, and behaviour (Behrman, 1975; Wolfe & Coceani, 1979; Wolfe, 1982 tered PGE2 on the output of gastric acid were studied in anaesthetized rats.
Methods

Measurement ofgastric acid secretion
Male Wistar rats weighing 250-300g were used after a fast of about 20 h. The animals were anaesthetized with urethane, 1.2g/kg, intraperitoneally and prepared for the measurement of gastric acid output as described previously (Puurunen & Karppanen, 1975) . Briefly, the trachea was cannulated and the rat was allowed to breathe spontaneously. A polyethylene cannula was introduced into the stomach through an incision in the duodenum and ligated about 0.5 cm from the pylorus. The stomach was irrigated through the duodenal cannula during the experiments with 4 ml portions of prewarmed (37°C) saline (pH 5.5-6.0). The volume of the solution recovered from the stomach was measured and the concentration of hydrogen ions determined with an automatic potentiometric titrator (TIlT 2, Radiometer, Copenhagen, Denmark). The left femoral vein was connulated for the intravenous injections which were given in a volume of 1 ml/kg. Mean arterial pressure was recorded continuously via a cannula inserted into the left femoral artery, and any rat in which it was lower than 80 mmHg before any treatment was discarded. The rectal temperature of the animals was kept at 37°C during the experiment. Intracerebroventricular administration I.c.v. administration was performed by the stereotaxic method described in detail by Paakkari (1980) . Briefly, an injection needle was introduced into the right lateral ventricle and a polyethylene tube filled with the PGE2 solution or vehicle was attached to it. The solution was allowed to flow into the ventricle by means of hydrostatic pressure in 10 l1 portions at 1 min intervals, the total volume being 30 ptl.
Electrical vagal stimulation
Both vagus nerves were exposed in the neck and ligated. A platinum electrode was applied to the left vagus distal to the ligature. The rats were subjected to artificial respiration via the tracheal cannula by using I.v. injection of 1 iu/kg of insulin increased the low basal output of acid within an hour, the maximal stimulation being observed after approximately 2 h. I.c.v. administration of 1 or 3 ytg of PGE2 performed 40min after insulin inhibited this stimulation in a dose-dependent manner ( Figure. 1) . The inhibitory effect of 1 Aig of PGE2 lasted less than 80 min, whereas in the rats which received 3 Lg PGE2, acid output remained significantly lower than in the control rats for the remaining 140min of the experiment (see Figure. 1 ).
Total acid output over the 3 h period after insulin was 219 ± 35 ptEq in the control rats (n = 7); 1 jig of PGE2 decreased it by 52% (to 105 ± 26 AEq, n = 7, P < 0.05) and 3ig of PGE2 by 72% (to 62± 21 IAEq, n = 7, P < 0.01).
Effect of i.v. injection of prostaglandin E2 on insulinstimulated gastric acid secretion I.v. injection of 1, 3 or 10 jg doses of PGE2 given 40
and 80 min after insulin did not affect the insulininduced stimulation of gastric acid secretion. Overall acid output over the 3 h period after insulin administration was 178 ± 57 pEq (n = 6) in the control rats and 228 ± 52jLEq (n = 6), 142± 48 glEq (n = 6) and 157 ± 43 ,tEq (n = 6), respectively, in the rats that at the beginning of the acetylcholine infusion did not affect the secretory response to acetylcholine whereas 3 Aig of PGE2 caused an inhibition lasting for at least 80 min.
Overall acid output over the 2 h period of the acetylcholine infusion (200 ± 36 pEq, n = 5) was not affected by 1 jg of PGE2 (157 ± 29 pEq, n = 5) whereas 3 glg of PGE2 decreased it by 59% (to 82 ± 22 tEq, n = 5, P < 0.05).
Discussion
Prostaglandins of A, E and I type are potent inhibitors of gastric acid secretion in animals and man.
It is widely accepted that they have a peripheral site of action, most probably at the level of the acidsecreting parietal cell. (Robert, 1981) . However in the present study, PGE2 strongly inhibited gastric acid secretion induced by insulin, electrical vagal stimulation or acetylcholine in anaesthetized rats when administered into the cerebral ventricle. The fact that the same or even higher intravenous doses did not affect gastric acid output indicates that upon i.c.v. administration PGE2 exerted its action in the brain and not peripherally after leakage from the central nervous system. The lack of effect of the i.v. injection of PGE2 doses used here is not in disagreement with the findings in the literature. According to Main & Whittle (1973 , a continous i.v. infusion of PGE2 at the rate of 2jig kg-I min-is needed to inhibit slight histamine or pentagastrin stimulation in anaesthetized rats. This would correspond to a dose of 280 jig/kg over 140 min, at which time 3 jig of PGE2 after i.c.v. administration still effectively inhibited gastric acid output induced by insulin ( Figure  1) . Similarly, in conscious gastric fistula rats in which the spontaneous output of acid approximately corresponds to the insulin stimulation of the present work, only very high subcutaneous doses (125 to 250 jg/kg) decrease gastric acid secretion (Main & Whittle, 1975) .
The stimulation of gastric acid secretion by insulin is due to a central activation of the vagus nerve through hypoglycaemia (Brooks, 1954) . Electrical vagal stimulation increases acid output by release of acetylcholine from the postganglionic nerve fibres, whereas exogenous acetylcholine exerts its action directly on parietal cells. I.c.v. administration of PGE2 inhibited all these stimulations. Therefore although originating from the brain, the final site of the inhibitory action of PGE2 is not central, but instead it must initiate neuronal or hormonal impulses in the brain which then act peripherally to inhibit gastric acid secretion.
The present results do not make clear the mechanism by which centrally administered PGE2 inhibits gastric acid secretion. However, the involvement of the sympathetic nervous system should be considered. In agreement with the previous reports (Hoffman & Schmid, 1979; Sir6n, 1981) , i.c.v. administration of PGE2 caused prompt increases in blood pressure and heart rate. Recently, Feuerstein, Adelberg, Kopin & Jacobowitz (1982) have found that centrally administered PGE2 increases plasma levels of catecholamines, especially of noradrenaline. These findings strongly suggest that central administration of PGE2 causes activation of the sympathetic nervous system. On the other hand, sympathomimetic compounds have an inhibitory effect on gastric acid secretion (Taylor & Nabi Mir, 1982) . Accordingly, the possibility that the inhibition of gastric acid secretion by i.c.v. administration of PGE2 is mediated by an activation of the sympathetic nervous system cannot be excluded.
Taken together, the present results indicate that PGE2 has a central inhibitory action on gastric acid secretion in anaesthetized rats. The possibility that PGE2 participates in the central control of gastric acid secretion therefore deserves further investigation.
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